Family Practice News Digital Network
SABCS: Addition of Everolimus Helps Slow Breast Cancer
This study found that the combination of the aromatase inhibitor exemestane (Aromasin) and everolimus (Afinitor) extends progression-free survival in women diagnosed with metastatic breast cancer by more ...
BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression
Combination of Everolimus and Exemestane Improves Progression-Free Survival ...
Novartis' Afinitor More Than Doubles PFS In Breast Cancer Patients